GlobalData on MSN11h
Rallybio doses first subject in Phase II trial of treatment for FNAIT in EuropeRallybio has dosed the first subject in a trial of a potential treament for foetal and neonatal alloimmune thrombocytopaenia (FNAIT).
For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...
Supreme Court's Justice Jamal Mandokhail on Wednesday raised question regarding the scope of the Army Act's jurisdiction, ...
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for priority review with a PDUFA date of July 22, 2025 ...
UK regulatory approval follows FemaSeed, FemVue and FemCerv clearance/approvals in the U.S., Europe, Canada and Israel.
We think the strategy to find more effective combination therapies in hematology and build a larger oncology and dermatology portfolio is solid, although we're waiting for key data before assuming the ...
Boca Raton, Florida Wednesday, February 12, 2025, 16:00 Hrs [IST] ...
Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback